Keyphrases
Diabetic
100%
Type 2 Diabetes Mellitus (T2DM)
100%
Macrovascular Disease
100%
Aldosterone Antagonism
100%
New Therapeutic Approaches
100%
Diabetes
66%
Type 1 Diabetes Mellitus (T1DM)
66%
Heart Failure
66%
Angiotensin-converting Enzyme Inhibitor (ACEi)
66%
Aldosterone
66%
Angiotensin II (Ang II)
66%
Renin-angiotensin-aldosterone System
66%
Clinical Trials
33%
Cardiovascular Risk
33%
Beneficial Effects
33%
Cardiovascular Disease
33%
Myocardial Infarction
33%
High Risk
33%
Intervention Studies
33%
Vascular Disease
33%
Nephropathy
33%
Blood Pressure Control
33%
Cardiovascular Prevention
33%
Inhibitor Therapy
33%
Metabolic Disorders
33%
Angiotensin Receptor Blockers
33%
Aldosterone Antagonists
33%
New Therapies
33%
Harmful Effects
33%
Pharmacological Approaches
33%
Medicine and Dentistry
Maturity Onset Diabetes of the Young
100%
Macrovascular Disease
100%
Aldosterone Antagonist
100%
Aldosterone
75%
Diabetes
50%
Diabetes Mellitus
50%
Cardiovascular Disease
50%
ACE Inhibitor
50%
Angiotensin II
50%
Congestive Heart Failure
50%
Blood Pressure
25%
Clinical Trial
25%
Disease
25%
Cardiovascular Risk
25%
Vascular Disease
25%
Cardiovascular System
25%
Myocardial Infarction
25%
Primary Prevention
25%
Angiotensin
25%
Renin Angiotensin Aldosterone System
25%
Renin
25%
Water-Electrolyte Imbalance
25%
Nephropathy
25%
Intervention Trial
25%
Angiotensin Receptor Antagonist
25%